Dr. Olaya Isabella Brewer Gutierrez, MD

Dr. Brewer Gutierrez practices at Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System.

Dr. Brewer Gutierrez's NPI, 1629420948, was assigned on July 11, 2016. Dr. Brewer Gutierrez holds Maryland license D86293.

Dr. Brewer Gutierrez's primary practice is Sibley Memorial Hospital, at 5255 Loughboro Rd NW, Washington, DC 20016 in The District County. The practice phone is (202) 537-4680.

Dr. Brewer Gutierrez's primary practice is Sibley Memorial Hospital in Washington, District of Columbia, part of Johns Hopkins Health System. Dr. Brewer Gutierrez is also affiliated with Johns Hopkins Bayview Medical Center. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Brewer Gutierrez to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Brewer Gutierrez practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Brewer Gutierrez's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Brewer Gutierrez is licensed in Maryland.

CMS data shows 805 Medicare services from Dr. Brewer Gutierrez across 23 procedure codes in 2024, for 436 Medicare patients. Medicare paid $92,504 for them.

CMS counts 436 Medicare patients who saw Dr. Brewer Gutierrez in 2024. The largest group is 65 to 74, with 223 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Brewer Gutierrez's median patient age at 64, with 55% women.

In 2024, Dr. Brewer Gutierrez wrote 357 Medicare Part D claims for 143 patients. 92% of them were for generic drugs. CMS names the drug for 258 of them, across 7 drugs with 11 or more claims each, at $6,348 in total drug cost. In 2023, CMS named 150 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Brewer Gutierrez for performance year 2024, reported as part of a group. CMS lists Dr. Brewer Gutierrez as offering telehealth. CMS counts 560 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Brewer Gutierrez, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 49 papers to Dr. Brewer Gutierrez, published from 2017 to 2022. 2020 was the busiest year, with 12. The most frequent topics are Esophageal Achalasia, Myotomy and Natural Orifice Endoscopic Surgery. Dr. Brewer Gutierrez has published most often in Endoscopy. Dr. Brewer Gutierrez's most frequent co-authors are Mouen A. Khashab, MD, Vivek Kumbhari, MD and Omid Sanaei, MD.

CMS Open Payments shows 125 general payments to Dr. Brewer Gutierrez from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 54% of the total. Boston Scientific Corporation paid the most, $34,584.